Great value at these levels, page-19

As far as I can see from two full afternoons of research (which practically makes me an expert, right???) the $13 mark is a very fair price for Invocare.

It's got good market share, non-threatening competition, very good growth numbers.... And as a fact of life people will continue dying.

After umming and ahhing for the weekend I finally put a buy order in tonight

See what happens over the next twenty years.